AB0024

· Gilead Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AB0024, covering 2012-05-03 to 2012-05-03. Get the full timeline:

Most recent: Clinical Trial Update: First-in-human Study of AB0024 to Evaluate Safety and Tolerability in Adults With Advanced Solid Tumors [Phase 1]